Topic resource collection
Approved comparison material connected to this topic.
3 resourcesRead both sides
BPC-157 (pentadecapeptide) and TB-500 (43-amino-acid sequence) target different phases of muscle-tendon healing. BPC-157 demonstrates superior efficacy in the inflammatory and proliferative phases. The first 10–14 days post-injur…
BPC-157 VEGF receptor activation; angiogenesis; collagen type I synthesis Inflammatory and proliferative (days 1–21) 200–300mcg daily Peri-injury IM or subQ abdominal Best first-line option for grade 1–2 strains; acts fastest in …
BPC-157 VEGF-mediated angiogenesis, collagen organization at injury site 200–400 mcg daily (human equivalent dose from animal models) Local subcutaneous or intramuscular near injury 30–40% reduction in healing time in animal tend…